| Trial | Updated / Type |
Status | Phase | Were Results Reported |
Reported Actual Enrollment |
(MeSH) Terms |
Why Stopped
Limitations And Caveats |
Annotator decisions |
|---|---|---|---|---|---|---|---|---|
| NCT00005067 Details | 2013-01-16 Interventional | 1 | 24 | Motexafin lutet… Prostatic Neopl… Recurrence Adenocarcinoma … Recurrent Prost… Stage I Prostat… Stage IIA Prost… Stage IIB Prost… | Administratively complete. - | |||
| NCT00101088 Details | 2013-01-14 Interventional | 1 | 21 | Imatinib Mesyla… MTOR Inhibitors Sirolimus Temsirolimus Blast Crisis Leukemia Leukemia, Myelo… Leukemia, Myelo… Leukemia, Myelo… Leukemia, Myelo… Accelerated Pha… Blastic Phase C… Chronic Myeloge… Chronic Phase C… Relapsing Chron… | - - | |||
| NCT00003613 Details | 2013-01-11 Interventional | 1 | - | Carmustine O(6)-benzylguan… Lymphoma Lymphoma, Non-H… Lymphoma, T-Cel… Lymphoma, T-Cel… Recurrent Cutan… Stage I Cutaneo… Stage II Cutane… | - - | |||
| NCT00862134 NCT00840021 Details | 2013-01-10 Interventional | 2 | 42 | Docetaxel Lenograstim Carcinoma, Non-… Lung Neoplasms Non-Small Cell … | Interim analysis indicated low probability of clinically significant result - | |||
| NCT00766337 Details | 2013-01-10 Interventional | 2 | 62 | MTOR Inhibitors Ranibizumab Sirolimus Temsirolimus Choroidal Neova… Macular Degener… Neovascularizat… Age-Related Mac… | - - | |||
| NCT00712491 Details | 2013-01-10 Interventional | 1/2 | 20 | MTOR Inhibitors Sirolimus Temsirolimus Choroidal Neova… Macular Degener… Neovascularizat… Age-related Mac… | - - | |||
| NCT00086983 Details | 2013-01-10 Interventional | 1 | - | Oxaliplatin Neoplasms Unspecified Adu… | - - | |||
| NCT01611506 Details | 2013-01-09 Interventional | 1/2 | 1 | Capecitabine Cetuximab Stomach Neoplas… Gastric Cancer | Outcome of EXPAND study (no benefit from adding cetuximab to the first-line chemotherapy in
advanced gastric cancer in the overall patient population) - | |||
| NCT00512668 Details | 2013-01-07 Interventional | 1 | 24 | Bicalutamide Flutamide Goserelin Leuprolide MTOR Inhibitors Nilutamide Sirolimus Temsirolimus Prostatic Neopl… Adenocarcinoma … Recurrent Prost… | - - | |||
| NCT00301795 Details | 2013-01-07 Interventional | 2 | - | Oblimersen Rituximab Lymphoma Lymphoma, Folli… Lymphoma, Non-H… Stage III Grade… Stage III Grade… Stage III Grade… Stage IV Grade … Stage IV Grade … Stage IV Grade … | - - | |||
| NCT00089089 Details | 2013-01-07 Interventional | 1 | 42 | Azacitidine Decitabine Hematopoietic/L… Unspecified Adu… | - - | |||
| NCT00087256 Details | 2013-01-07 Interventional | 3 | 18 | Celecoxib Colonic Neoplas… Colorectal Canc… | For scientific, logistic, and administrative reasons. - | |||
| NCT00080847 Details | 2013-01-07 Interventional | 2 | 160 | Cyclophosphamid… Doxorubicin Liposomal doxor… Oblimersen Prednisone Rituximab Vincristine Lymphoma Lymphoma, Large… Lymphoma, Non-H… Contiguous Stag… Noncontiguous S… Stage III Adult… Stage IV Adult … | - - | |||
| NCT00894023 Details | 2013-01-04 Interventional | 3 | 150 | Abciximab Infarction Myocardial Infa… Acute Myocardia… | the study was stopped because the sample size was very difficult to achieve. - | |||
| NCT00561197 Details | 2013-01-04 Interventional | 1/2 | 13 | Gossypol acetic… Locally Advance… | Drug not being developed for this indication - | |||
| NCT00837759 Details | 2013-01-03 Interventional | 2 | 7 | Dexlansoprazole Lansoprazole Sitagliptin Pho… Diabetes Mellit… Diabetes Mellit… Autoimmune Diab… Diabetes Mellit… | Changes to study personnel. - | |||
| NCT00902525 Details | 2012-12-31 Interventional | 2 | 25 | Antibodies, Mon… Lymphoma Lymphoma, B-Cel… Lymphoma, Large… Diffuse Large B… | After enrolling 25 patients an interim analysis was done.The study was discontinued in the
absence of the minimum number of 6 patients free of events - | |||
| NCT00617058 Details | 2012-12-31 Interventional | 2 | 1 | Metformin Weight Gain | Terminated in lieu of similar,competing large, multi-site study. In terms of study limitations, this research study was only able to enroll a single study participant before the trial was terminated prematurely due to study start-up for a larger, multisite effort examining similar outcome measures. | |||
| NCT00589693 2007-004646-33 Details | 2012-12-28 Interventional | 3 | 274 | Cilastatin Cilastatin, Imi… Doripenem Imipenem Pneumonia Pneumonia, Vent… Ventilator-Asso… | Observed lower cure rates and higher mortality rates in one of the treatment groups. 41 patients (21 doripenem, 20 imipenem-cilastatin) were enrolled at 5 sites that were found to be Good Clinical Practice non-compliant and were excluded from the primary efficacy and safety analyses. | |||
| NCT01312064 Details | 2012-12-27 Interventional | 4 | 2 | Everolimus Rituximab Tacrolimus Thymoglobulin Renal Insuffici… | Difficulty collecting - |